Category: Tapering

Can you become dependent on gabapentin at the dose your doctor prescribed?

Yes, and it happens more quietly than with most medications a doctor hands out. Gabapentin, sold as Neurontin, and its close relative pregabalin, sold as Lyrica, belong to a small family called gabapentinoids, and both can leave you unable to stop without symptoms.

If you have tried to lower your dose and felt worse, you may already know this. What you may not have been told is that the feeling has a name, that it was predictable, and that it does not mean the original problem is back. How does a medication with a reputation for being harmless do that?

Dependence forms because the nervous system adapts to whatever it is given.

Gabapentin binds to part of the calcium channels that nerve cells use to release their signals, and the Neurontin label says plainly that the precise mechanism of its effects is unknown. What clinical experience shows is that a nervous system given a steady daily dose of any calming medication settles into a new normal that assumes the medication will be there.

One theory is that, when the medication is removed, the adaptation runs in reverse for a while, but the label describes no withdrawal mechanism. In clinical experience it happens at ordinary doses, in people who never took an extra capsule, whatever the label has or has not evaluated.

Physical dependence is not addiction. Dependence is a medical condition produced by a prescription taken exactly as written, and its treatment is a gradual, planned taper, not a program for a problem you do not have.

How do you notice gabapentin dependence?

Patients almost never describe it as dependence. They describe a missed or late dose that brought on anxiety, irritability, a headache, poor sleep, or the pain the medication was started for, within hours rather than days. When the next dose fixes it, most people conclude that they still need the medication.

A second tell is what happens when a reduction is attempted. Symptoms appear, they look like the original condition, and everyone concludes that it has come back. Pain or anxiety that returns within a day or two of a cut is more often the nervous system objecting than the old illness reappearing on cue.

The third tell shows up on a dose that has not changed in months: restlessness, poor sleep, a low hum of anxiety, or a fogginess that the next dose only partly relieves. A common pattern is a patient given gabapentin for nerve pain after an operation, kept on it for two years because nobody set a stop date, who meets all three tells in the week a refill runs late.

What does gabapentin withdrawal feel like?

It can feel a great deal like benzodiazepine withdrawal. Anxiety, insomnia, sweating, nausea, headache, a racing heart, tremor, and inner restlessness are the usual complaints, and the Neurontin label adds agitation, disorientation, and confusion after sudden stopping, in reports it describes as rare and mostly at higher than recommended doses. The label’s dependence section is thin and admits that dependence has not been evaluated in human studies.

The label is not thin about one thing. Gabapentin is an antiepileptic medication, and the label warns that these medications should not be stopped abruptly because seizures can increase, directing that any reduction or switch be made gradually over at least a week. Treat that week as a floor, not as a plan for a nervous system that has leaned on the medication for years.

A few things are never withdrawal until a doctor has said so. A seizure, chest pain, sudden loss of vision or hearing, new or worsening confusion, or thoughts of harming yourself are reasons to get emergency care now, not to wait and see, and if self-harm is in play, call or text 988 first. The label notes that antiepileptic medications can raise the risk of suicidal thoughts, so do not talk yourself out of that call because you assume it is the taper.

While you are still taking it, the label warns of drowsiness and dizziness, with a caution against driving until you know how it affects you, of serious slowed breathing when it is combined with other sedating medications, benzodiazepines among them, or in people whose breathing is already impaired, and, rarely, of a dangerous drug reaction with rash and fever.

Why do prescribers overlook it?

Gabapentin is usually added to a treatment plan rather than planned into it. It arrives to cover nerve pain during another taper, to help with sleep, or after an operation, and no one writes down the day it should end. The first prescription becomes the standing prescription without anyone deciding that it should.

The second reason is reputation. The Neurontin label states that gabapentin is not a scheduled drug. Some states control it on their own, and pregabalin is federally controlled, but in medicine we have tended to read “not scheduled” as though the nervous system had read the schedule too.

The third reason is diagnostic. When a reduction brings on anxiety, insomnia, or pain, the simplest explanation on the chart is that the original condition needs continued treatment. Withdrawal is rarely on the list, so the dose goes back up and the question is closed for another year.

Fortunately, gabapentin can be tapered, and the principles are familiar.

The Maudsley Deprescribing Guidelines give gabapentinoids their own chapter and apply the same approach they use for benzodiazepines. The taper begins from a stable place, a steady dose on a steady schedule until symptoms have settled, and only then comes the first small cut.

The cuts then shrink as the dose falls, in what the guidelines call a hyperbolic shape, because the last portion of the dose does a disproportionate share of the work. While a dimmer switch is not a perfect analogy, it holds in one respect: the first part of the turn barely changes the light and the last few degrees change it the most, so a steady hand slows down near the bottom. Cut smaller the lower you go.

Gabapentin comes in low-strength capsules and, according to the Neurontin label, in a commercial oral solution, so small cuts remain possible at the low end, and where a finer step is needed a compounding pharmacy can prepare a liquid. When symptoms flare after a cut, the dose is held until they settle, and if you take more than one dependence-forming medication, one comes down at a time.

What if the gabapentin was added during your benzodiazepine taper?

A prescriber adds it for the sleep, the pain, or the anxiety of a benzodiazepine taper, it helps for a while, and the patient who finishes the benzodiazepine finds a second medication waiting for its own taper. That is how much of the gabapentin dependence Dr. Leeds sees comes to light.

Dr. Leeds’ rule for anything added during a taper is that its exit plan is written on the day it is started. Anything added without one tends to stay, and the polypharmacy trap is built one helpful addition at a time. If you are offered gabapentin mid-taper, ask then how long it is meant to last and how it will come off.

If it was added years ago, the answer is not to hurry either medication. Finish the taper you are on, stabilize, and begin the second at the same careful pace, letting your prescriber judge which should come first.

Is the second taper really starting over?

No, although it can feel that way. A nervous system that has just finished a benzodiazepine taper is often still sensitized and quick to notice change, so a gabapentin taper taken too fast can hit as hard as the first one did. Some patients barely notice it, others need the same patience they needed the first time, and there is no knowing in advance.

Yet, you are not starting over. You already know what a window and a wave are, that holding is protection, and that a bad week after a cut is information rather than failure. And, when cuts stop working, the remedy is the one you learned the first time, a longer hold rather than a firmer resolve.

What should you ask your prescriber?

Begin with the question nobody asked at the start: what happens if I stop this? Follow it with what the deprescribing plan is, what a slow taper would look like, and whether a liquid form is available for small steps. A prescriber who has thought about gabapentin will have answers, and one who has not will at least have been asked.

An absent answer is itself useful, because it tells you the plan will have to be made now, with you in the room. The pace belongs to you as much as to the prescriber: if the taper is too fast, the doctor must slow it, and if it is comfortable, the two of you may agree to go a little faster, as tolerated.

That plan will look much like the one that already worked for you: a stable start, cuts that shrink as the dose falls, and holds when your body asks for them. You already know how to wait through a hard week, and now you know what to ask for.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

What does kindling mean when people talk about benzodiazepines?

Kindling is a borrowed word for a nervous system that has become more reactive after repeated abrupt stops. In medicine, we took the term from neurology, where it described a brain that seemed to learn to seize more easily each time it was provoked. In a benzodiazepine patient it describes a second or third withdrawal that arrives sooner, runs hotter, and lasts longer than the first, out of proportion to the dose.

The word carries its own picture, and it is the one analogy here. Kindling is the small dry wood that catches from a spark, and each time a fire is lit and stamped out, what is left behind catches faster than the fresh wood did. While a brain is not a woodpile, the picture explains why the sensible response is to stop striking sparks.

So, two questions remain. Is kindling real, and what should it change about the next attempt?

Why can a second taper feel harder than the first?

The brain compensates for a benzodiazepine by turning up its own excitability, and when the drug is removed faster than that compensation can unwind, the excess shows itself as withdrawal. Restarting the medication covers it up again, but there is no reason to think it undoes it.

A too-fast taper is usually not one event but three: a reduction that outran the nervous system, a stretch of severe withdrawal, and a reinstatement. In clinical experience, a nervous system that has lived through a full withdrawal episode tends to react more quickly and more strongly the next time the dose moves.

When the stops and restarts came from a prescriber rather than from you, the cycle has its own article. This piece is about a nervous system that already carries that history.

Is kindling proven, and what does the Ashton Manual say?

Kindling is not proven, and you deserve to hear that plainly. Nobody has settled what changes in the brain after repeated withdrawals, and the evidence for benzodiazepines is thinner than the confidence with which the word gets used. What we have is clinical experience, which varies from one physician to the next.

Dr. Leeds’ view is that the pattern is recognizable in the people who arrive after two or three failed attempts, and that a history of rapid withdrawals is a reason for more caution, never less. A gentle plan costs little if kindling turns out to be overstated.

The Ashton Manual does not use the word kindling at all. In fact, Chapter III, in its section on the course of withdrawal, says that eventual success in withdrawal is not affected by previous attempts at withdrawal. Professor C. Heather Ashton wrote that after years of running a withdrawal clinic.

Both statements can be true, because the manual’s reassurance is about where you end up and kindling is about how hard the next stretch is. The manual itself supplies the reason: Chapter II warns that abrupt or over-rapid withdrawal can produce severe symptoms including convulsions, and Chapter III observes that protracted symptoms are far less common in people who tapered slowly under their own control.

What harms a nervous system is the abruptness of a stop. So, a previous attempt counts against you only to the degree that it was abrupt, and the next one does not have to be abrupt at all.

Your symptoms on the last attempt were not in your head.

People who arrive after repeated failed tapers have often been told that their symptoms were anxiety or a personality trait. Some were told this by the same doctor who set the pace.

Physical dependence is not addiction. Dependence is the body’s adaptation to a medication taken exactly as prescribed, and withdrawal is what that adaptation looks like when the medication is removed faster than the body can adjust. A taper that did not hold was a pace problem, and pace, unlike a personality trait, can be changed.

Read as kindling, the same symptoms were the predictable response of a nervous system that had already been provoked once. That argues for a slower plan, and it gives you grounds to expect the plan to work.

Stabilize before you reduce anything.

The first move in a taper after failed attempts is to not taper. A nervous system that has just been through withdrawal and reinstatement needs weeks, and sometimes months, at one steady dose before it is ready for a reduction. None of that time is wasted, because nothing is being provoked.

Stable means predictable, not comfortable. While a rough stretch during a hold can feel like proof that the hold is failing, it is often the nervous system catching up with earlier changes, and the reasons a hold can feel worse have their own article.

A common pattern: someone came off in ten days at a facility, was restarted within a month, and tried again on a standard outpatient schedule. The second attempt stalled at the second cut, and what worked was three months at a steady dose before anyone touched it.

Cuts get smaller than last time, and they shrink as the dose falls.

If the pace that failed last time was the standard pace, the plan this time starts slower than that. The Ashton Manual’s schedules in Chapter II shrink each reduction as the dose comes down, and the Maudsley Deprescribing Guidelines describe reductions in proportion to the current dose. The right size is the one your nervous system tolerates, worked out with your prescriber one cut at a time.

Precision matters more in a reactive nervous system than in a calm one. Once the dose is below what tablets can be split evenly, a liquid formulation or a compounded preparation keeps each reduction exact, because a dose that varies from day to day is a series of small withdrawals. Unfortunately, precision is often the first thing a rushed plan gives up, and a kindled nervous system does not grade estimates generously.

A longer-acting benzodiazepine may smooth the ride.

Short-acting benzodiazepines wear off between doses, and the dip before the next dose is a small withdrawal in its own right. The Ashton Manual, in Chapter II, advises switching to a long-acting benzodiazepine such as diazepam because a short-acting drug cannot give a smooth decline in blood levels.

That switch is a crossover taper, done in stages over weeks rather than in one swap, and it is not right for everyone. Some people do not tolerate diazepam, so whether to make the change is a decision between you and a prescriber who knows the substitution well.

Hold through a flare, with a prescriber who will let you.

Flares happen even in a slow, precise taper. When one arrives, the first move is to stop reducing and stay where you are until the days become predictable again, and the Ashton Manual puts it plainly: if you reach a difficult point, you can stop there for a few weeks if necessary. The Manual adds that you should try to avoid going backwards, while the Maudsley Deprescribing Guidelines allow a return to the last dose at which you were stable, so the two references differ on that point. Whether a particular flare calls for a step back up to the previous dose is a decision for you and your prescriber to make together, case by case, and it is not one to answer alone.

The most reliable way to kindle a nervous system a third time is a prescriber who hears “I need to slow down” as resistance. So, part of preparing for the next attempt is finding someone who treats your account of the last one as clinical information. A discharge date is an administrative fact, and no nervous system has ever read one.

The Food and Drug Administration’s 2020 update to the benzodiazepine label warns that abrupt discontinuation or rapid dose reduction can bring on withdrawal reactions, including seizures, that can be life-threatening, and it calls for a gradual taper. Never stop a benzodiazepine suddenly on your own. If you have a seizure, chest pain, or a sudden loss of vision or hearing, or if you are thinking about harming yourself, call 911 or go to the nearest emergency department, and call or text 988 if self-harm is part of it.

What if you have already been through this two or three times?

Then you are the person the Ashton Manual’s reassurance was written for. Your previous attempts have not lowered your chances of finishing, and they have told you, at a high price, how fast your nervous system can be asked to move.

Fortunately, everything that made the earlier attempts fail can be changed on the next one. The pace, the size of each cut, the drug, the willingness to hold, and the person writing the plan are all decisions, and none of them is fixed by what happened before.

Yet, no physician can honestly give you a timeline, because the manual’s sentence says nothing about how long it takes. What you can hold on to is that the next attempt is made with a partner, at a pace the two of you set together, and that the last failed taper was the last time anyone needs to strike a spark.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.